Results
1 -
5 of
5
(Click
here to explore results)
Natural product and natural product derived drugs in clinical trials . Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
SGLT inhibitors as antidiabetic agents: a comprehensive review . Rahul P. Kshirsagar, Abhishek A. Kulkarni, Rashmi S. Chouthe, Shahebaaz K. Pathan, Hemant D. Une, G. Bhanuprakash Reddy, Prakash V. Diwan, Siddique Akber Ansari, Jaiprakash N. Sangshetti
, RSC Adv.
, 2020
, 10
, 1733
Sodium–glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class . Paula Nogueira da Silva, Raissa Alves da Conceição, Rodolfo do Couto Maia, Maria Leticia de Castro Barbosa
, Med. Chem. Commun.
, 2018
, 9
, 1273
On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin . Vincent Mascitti, Benjamin A. Thuma, Aaron C. Smith, Ralph P. Robinson, Thomas Brandt, Amit S. Kalgutkar, Tristan S. Maurer, Brian Samas, Raman Sharma
, Med. Chem. Commun.
, 2013
, 4
, 101
Comprehensive structure–activity relationship (SAR) investigation of C -aryl glycoside derivatives for the development of SGLT1/SGLT2 dual inhibitors . Yunting Xin, Shuhao Zhou, Huibin Wang, Baichun Hu, Zhigang Zhang, Jian Wang, Tiemin Sun
, New J. Chem.
, 2021
, 45
, 14193